Depression Clinical Trials in Chicago

Showing 101-120 of 123 trials

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

NCT00095823

This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.

Major Depressive Disorder

Bristol-Myers Squibb1,200 participantsStarted Jun 2004

Garden Grove, California, United States • Northridge, California, United States • Washington D.C., District of Columbia, United States +17 more locations

TERMINATEDPHASE32.2 miles

Treatment for Chronic Depression

NCT00204152

The purpose of this study is to test the clinical efficacy of two psychotherapies for early onset chronic major depression, including Behavioral Activation (Jacobson et al., 2001), and an integrated version of Behavioral Activation and Stress Innoculation Coping (BASIC) for short-term (16 weeks) of individual psychotherapy for adults with chronic major depression. The control condition is an individual workbook condition of Behavioral Activation. These psychotherapies focus on behavior activation, stress reduction and coping strategies to counter depressive symptoms.

Major Depressive Disorder

University of Chicago30 participantsStarted Jun 2004

Chicago, Illinois, United States

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Treatment for Chronic Depression

Depression Trials in Other Cities

Doula Support for Young Mothers: A Randomized Trial

Primary Care Internet-Based Depression Prevention for Adolescents (CATCH-IT)

EEG Biomarkers for Predicting Response to Antidepressant Therapy

Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention

Seroquel in Bipolar Depression Versus SSRI

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

Genetics of Fibromyalgia

AZD7268 Safety and Tolerability Study

Expanding and Testing VA Collaborative Care Models for Depression

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder

The Clinic Treatment Project

Other Conditions in Chicago